Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2014
10/02/2014WO2014157107A1 Polypeptide having sialylated sugar chains attached thereto
10/02/2014WO2014156339A1 Postprandial gastrokinetic agent
10/02/2014WO2014155376A1 Methods of treating myeloid leukemia
10/02/2014WO2014154891A1 Cgrp receptor agonist for hiv treatment or prevention
10/02/2014WO2014154187A1 Preparation and use of dimerized fusion protein
10/02/2014WO2014154019A1 Long-lasting immune fusion protein for treating diabetes
10/02/2014WO2014153666A1 Indoline compounds as granzyme b inhibitors
10/02/2014US20140296478 Method for selecting a candidate drug compound
10/02/2014US20140296165 Use of tight junction antagonists to treat inflammatory bowel disease
10/02/2014US20140296164 Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
10/02/2014US20140296163 Methods and Compositions for the Treatment of Gastrointestinal Disorders
10/02/2014US20140296162 Whey Protein Composition with a Reduced Astringency
10/02/2014US20140296160 Stabilized alpha helical peptides and uses thereof
10/02/2014US20140296159 Method for Therapeutic Replenishment and Enrichment of Ocular Surface Lubrication
10/02/2014US20140296158 Sustained action formulation of cyclosporin form 2
10/02/2014US20140296157 Compositions and methods for preparing a subject for organ or non-organ implantation
10/02/2014US20140296154 Method of preventing development of psoriatic lesions
10/02/2014US20140296152 Stem Cell Derived Factors for Treating Pathologic Conditions
10/02/2014US20140296149 Compositions and Methods for the Treatment of Cardiac Surgery-Associated Acute Kidney Injury with Annexin A1 Peptide
10/02/2014US20140296148 Medicament for therapeutic treatment and/or improvement of sepsis
10/02/2014US20140296147 Methods of treating or preventing blood loss during surgery using the serine protease inhibitor mdco-2010
10/02/2014US20140296145 Modified Human Growth Hormone Polypeptides and Their Uses
10/02/2014US20140296143 Angiotensin-(1-7) As A Chemoprevention Agent
10/02/2014US20140296136 Hcv ns3 protease inhibitors
10/02/2014US20140296135 Medicament for the treatment of fungal infections particularly aspergillosis
10/02/2014US20140296130 Novel inhibitors of mammalian tight junction opening
10/02/2014US20140296101 Secreted proteins and uses thereof
10/02/2014US20140295549 Methods and compositions for inducing apoptosis by stimulating er stress
10/02/2014US20140294977 Radiation-Sterilized Biodegradable Drug Delivery Composition
10/02/2014US20140294969 Method and formulation for inhalation
10/02/2014US20140294951 Oral formulations mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2D
10/02/2014US20140294945 Methods and devices for forming treatment agent carriers
10/02/2014US20140294925 Formulations combining ramoplanin and rhamnolipids for combating bacterial infection
10/02/2014US20140294923 Acth for treatment of migraine headache
10/02/2014US20140294913 Biodegradable bone fillers, membranes and scaffolds containing composite particles
10/02/2014US20140294902 Novel a4b7 peptide antagonists
10/02/2014US20140294900 Flagellin related polypeptides and uses thereof
10/02/2014US20140294898 Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
10/02/2014US20140294894 Transcutaneous delivery of therapeutic agents
10/02/2014US20140294885 Heterologous expression of neisserial proteins
10/02/2014US20140294881 Proteases producing an altered immunological response and methods of making and using the same
10/02/2014US20140294874 Apoaequorin for reducing neuronal injury due to ischemia
10/02/2014US20140294865 Amatoxin-conjugates with improved linkages
10/02/2014US20140294860 Means and methods for treating and/or preventing natural ahr ligand-dependent cancer
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294821 Factor viii chimeric and hybrid polypeptides, and methods of use thereof
10/02/2014US20140294820 Fibroblast growth factor receptor inhibition for the treatment of disease
10/02/2014US20140294816 Combination therapy for the treatment of ocular neovascular disorders
10/02/2014US20140294803 Methods for treating headache
10/02/2014US20140294802 Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
10/02/2014US20140294799 Use of compositions having a low polyamine content in the prevention or treatment of adverse effects linked to cancer treatment
10/02/2014US20140294798 RbAp48 TRANSGENIC MICE FOR DRUG DISCOVERY IN AGE-RELATED MEMORY DECLINE
10/02/2014US20140294797 Non-cytotoxic protein conjugates
10/02/2014US20140294794 Methods for treating bleeding disorders using a platelet subpopulation
10/02/2014US20140294788 Methods for enhancing muscle protein synthesis following concurrent training
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/02/2014US20140294761 Treatments for migraine and related disorders
10/02/2014US20140294760 Novel cell and therapeutical and diagnostical methods based thereon
10/02/2014US20140294756 Long-Term Storage of Non-Glycosylated Recombinant Human G-CSF
10/02/2014US20140294755 Materials and Methods Relating to Stem Cell Mobilization by Multi-Pegylated Granulocyte Colony Stimulating Factor
10/02/2014US20140294754 Use of tumor fas expression to determine response to anti-cancer therapy
10/02/2014US20140294738 Treatment of rhinitis
10/02/2014US20140294726 Methods for diagnosing and treating alzheimer's disease by administering an anti-angiogenic agent
10/02/2014US20140294723 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and/or their cancerous counterpart
10/02/2014US20140290647 Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders
10/01/2014EP2784093A1 Polyethylene glycol-modified integrin blocker hm-3 and use thereof
10/01/2014EP2784090A1 Compositions for the treatment of systemic onset juvenile idiopathic arthritis
10/01/2014EP2784085A1 Human insulin analogue and acylated derivative thereof
10/01/2014EP2784084A1 IL-17 A/F heterologous polypeptides and therapeutics uses thereof
10/01/2014EP2784082A1 Disease site-delivering pharmaceutical compositions comprising paclitaxel.
10/01/2014EP2783701A2 Extended treatment of multiple sclerosis
10/01/2014EP2783698A1 Agents and methods for modulating macrophage inhibitory cytokine (MIC-1) activity
10/01/2014EP2783697A2 VIP Fragments and Methods of Use
10/01/2014EP2783696A1 Phosphorylation on the thr-248 and/or thr-250 residues of transcription factor e2f4 as a therapeutic target in pathological processes associated with somatic polyploidy
10/01/2014EP2783695A1 Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
10/01/2014EP2783694A2 Peptide sequences and compositions from Anopheles gambiase
10/01/2014EP2782928A1 Mutations of histone proteins associated with proliferative disorders
10/01/2014EP2782600A1 Combination therapy using anti - cd20 antibody and human il-15
10/01/2014EP2782593A2 Polypeptides having lysozyme activity and polynucleotides encoding same
10/01/2014EP2782592A1 Polypeptides having lysozyme activity and polynucleotides encoding same
10/01/2014EP2782591A1 Lactoferrin and the white matter
10/01/2014EP2782590A2 Radiation-sterilized biodegradable drug delivery compositions
10/01/2014EP2782589A2 Anti-microbial peptides and methods of use thereof
10/01/2014EP2782588A1 Methods and compositions for the treatment of diabetes and related symptoms
09/2014
09/30/2014US8849441 Systems, devices, and methods for making or administering frozen particles
09/30/2014US8846894 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
09/30/2014US8846893 Non-ionically bound constructs, and compositions and kits comprising domains
09/30/2014US8846876 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
09/30/2014US8846865 Endolysin OBPgpLYS
09/30/2014US8846862 Microwave-assisted peptide synthesis
09/30/2014US8846861 Peptide clearing agents
09/30/2014US8846859 Compositions and methods of use of targeting peptides against placenta and adipose tissues
09/30/2014US8846771 Compositions and methods of delivery of pharmacological agents
09/30/2014US8846759 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
09/30/2014US8846758 Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia
09/30/2014US8846686 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846644 Phosphate-containing nanoparticle delivery vehicle
09/30/2014US8846625 Glucagon-like peptide-2 analogs
09/30/2014US8846624 Modified protein polymers
09/30/2014US8846623 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 3163